• SENSEX 73,257.62
    -341.05 (--0.46%)
  • BANKNIFTY 53,974.90
    -391.80 (--0.72%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,160.50 1,152.30(%)
  • Piramal Pharma
    235.45 231.85(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    189.95 227.00(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Cholaman.Inv.&Fn
    1,555.00 1,952.00(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • Acutaas Chemical
    3,690.00 1,571.20(%)
  • One 97
    1,640.50 1,856.50(%)
  • Ola Electric
    37.44 51.84(%)
  • Sahajanand Medi
    481.15 347.50(%)
  • Swiggy
    183.05 174.30(%)
  • Bajaj Finance
    918.00 1,177.60(%)
  • Infosys
    1,103.50 980.30(%)
  • Patanjali Foods
    352.00 613.95(%)
  • Netweb Technol.
    4,490.00 5,810.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syschem (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 6001.0
  • ISIN : INE121D01036
35.86 3 (7.95%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    32.65

  • Today’s High

    37.79

  • Open

    34.04

  • Perv Close

    33.22

  • 52W Low

    28.81

  • 52W High

    60.95

Key Indicators

  • P/E(TTM)

    31.18

  • Mar.Cap (₹Cr.)

    192.27

  • Div & Yield %

    0.00

  • Book Value(₹)

    26.86

  • Debt-Equity Ratio

    7.95

  • AGM Date

    27-Oct-2026

  • EPS

    1.15

  • P/E Ratio

    31.18

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    192.27

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    53.62

  • BV (₹)

    26.90

  • Sales( ₹ in Cr.)

    654.63

  • NP (in Cr.)

    10.93

  • NP Var(%)

    2259.0

  • Div%

    0.0

  • CPS (₹)

    2.80

  • EPS (₹)

    2.00

  • Traded Value (₹ in Lakhs)

    192.27

  • 52 Week High

    60.95

  • 52 Week Low

    28.81

  • Price BSE

    36.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    192.27

  • P/C Ratio

    12.90

  • P/E Ratio

    17.70

  • Price Vs.BV

    2.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 654.63 386.23 233.48 130.38 65.63 74.41
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 654.63 386.23 233.48 130.38 65.63 74.41
Other Income 0.02 0.04 0.17 0.25 0.13 0.26
Stock Adjustments -14.49 3.65 22.25 -1.12 0.88 -5.44
Total Income 640.16 389.92 255.90 129.51 66.64 69.23
EXPENDITURE :            
Raw Materials 508.58 310.87 197.91 92.46 46.97 55.42
Power and Fuel Cost 5.78 2.90 2.84 2.15 2.39 2.87
Employee Cost 10.36 8.25 6.08 4.40 4.54 4.10
Other Manufacturing Expenses 5.46 5.19 4.35 2.95 3.46 2.92
Selling and Administration Expenses 88.13 58.29 37.32 18.30 8.41 8.47
Miscellaneous Expenses 0.74 0.40 0.25 0.35 0.18 0.36
Employee Benefit Expenses 10.36 8.25 6.08 4.40 4.54 4.10
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 619.05 385.90 248.75 120.61 65.95 74.14
Operating Profit 21.11 4.03 7.15 8.89 0.69 -4.90
Interest 2.26 0.07 0.25 0.04 0.28 0.06
Gross Profit 18.85 3.96 6.90 8.85 0.41 -4.96
Depreciation 4.06 2.95 2.79 2.70 2.58 2.35
Profit Before Tax 14.79 1.01 4.11 6.15 -2.17 -7.31
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 3.86 0.55 1.35 1.64 -0.47 -1.75
Reported Net Profit 10.93 0.46 2.76 4.51 -1.71 -5.57
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 -0.28
Adjusted Net Profit 10.93 0.46 2.76 4.51 -1.71 -5.29
Adjustment below Net Profit 0.00 0.00 0.00 0.12 0.00 0.00
P & L Balance brought forward -10.64 -11.10 -13.87 -18.50 -16.79 -11.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 0.28 -10.64 -11.10 -13.87 -18.50 -16.79
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 2.23 0.11 0.69 1.42 -0.73 -2.58
Earnings Per Share(Adj)-Unit Curr 2.23 0.11 0.69 1.30 -0.67 -2.37
Book Value 24.98 20.98 14.29 6.99 2.60 2.79
Book Value(Adj)-Unit Curr 24.98 20.98 14.29 6.42 2.39 2.56

Shareholding Pattern

  • Promoter Group

    63.38%

  • Public Share Holding

    36.62%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 33,983,610 63.38 33,983,610 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 33,983,610 63.38 33,983,610 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 31,130 0.06 31,130 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 31,130 0.06 31,130 1
2] Non Institution
Bodies Corporate 2,919,902 5.45 2,888,802 86
Clearing Members 354,646 0.66 354,646 19
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 363,904 0.68 211,204 273
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,018,421 1.90 1,018,421 256
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,712,150 14.38 7,712,150 104
Individuals holding nominal share capital up to Rs. 1 lakh 7,106,010 13.25 7,007,408 12,216
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 75,920 0.14 75,920 2
Sub Total 19,600,760 36.56 19,318,358 12,969
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 53,615,500 100.00 53,333,098 12,983

Company Background

Syschem (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syschem (India) Ltd
  • BSE Code : 6001.0
  • ISIN : INE121D01036

  • Incorporation Year

    1993

  • Registered Office

    Tehsil Kalka
    Bargodam Village, Panchkula,
    Haryana-133302

  • Telephone

    91-172-3077777

  • FAX

    91-172-3077700

  • Chairman

  • Managing Director

    Suninder Veer Singh

  • Company Secretary

    Shikha Kataria

  • Auditor

    STAV & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99,
    Madangir Behind LSC,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Syschem (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syschem (India) 35.86 654.65 654.63 31.18 14.88
Abbott India 25,488.50 7,217.19 6,929.05 33.54 43.78
Astrazeneca Phar 6,073.10 2,304.07 2,275.58 89.51 27.86
Glaxosmi. Pharma 2,488.75 3,932.76 3,790.20 39.76 58.17
Novartis India 1,847.40 393.10 354.33 46.65 15.94
Cipla 1,350.00 20,102.60 18,979.95 41.15 13.88
Bliss GVS Pharma 643.55 773.53 729.81 59.81 12.51
Amrutanjan Healt 490.45 520.13 502.55 26.27 24.16
Fermenta Biotec. 449.00 474.15 450.25 20.96 18.77
Guj. Themis Bio. 352.45 168.25 165.82 94.24 18.05
Ambalal Sarabhai 35.40 19.52 3.94 65.56 6.77